Hepatocellular Carcinoma Genetic Classification
- PMID: 37796642
- PMCID: PMC10686192
- DOI: 10.1097/PPO.0000000000000682
Hepatocellular Carcinoma Genetic Classification
Abstract
Hepatocellular carcinoma (HCC) represents a significant global burden, with management complicated by its heterogeneity, varying presentation, and relative resistance to therapy. Recent advances in the understanding of the genetic, molecular, and immunological underpinnings of HCC have allowed a detailed classification of these tumors, with resultant implications for diagnosis, prognostication, and selection of appropriate treatments. Through the correlation of genomic features with histopathology and clinical outcomes, we are moving toward a comprehensive and unifying framework to guide our diagnostic and therapeutic approach to HCC.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Conflicts of Interest and Source of Funding: The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article. Funding was provided by NIAAA R01AA023146 (to L.M.); NCI R01CA236591 (to L.M.); NCI U01CA230690 (to L.M. and K.S.).
Figures
References
-
- Cancer IAfRo. All cancers fact sheet. World Health Organization. December, 2020. (https://gco.iarc.fr/today/data/factsheets/cancers/39-All-cancers-fact-sh...).
-
- Group USCSW. U.S. Cancer Statistics Data Visualizations Tool, based on 2021 submission data (1999-2019): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. June 2022. (www.cdc.gov/cancer/dataviz).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical